Case Reports:

This article has an addendum. Addendum in: Oncotarget. 2022; 13:1271-1271.

Multiple primary lung cancer displaying different EGFR and PTEN molecular profiles

Zhouyu Zhu, Tao Yu and Ying Chai _

PDF  |  HTML  |  How to cite

Oncotarget. 2016; 7:81969-81971. https://doi.org/10.18632/oncotarget.13046

Metrics: PDF 1566 views  |   HTML 1848 views  |   ?  


Zhouyu Zhu1, Tao Yu1 and Ying Chai1

1 Department of Thoracic Surgery, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China

Correspondence to:

Ying Chai, email:

Keywords: multiple primary lung cancer, EGFR, PTEN, gefitinib

Received: August 15, 2016 Accepted: October 28, 2016 Published: November 03, 2016


We present a case of multiple primary lung cancer(MPLC) displaying heterogeneous EGFR and PTEN molecular profiles. Considering the physical condition of patients, the patient underwent surgical resection of the right lung lesion displaying gefitinib-insensitive and continued gefitinib treatment for the gefitinib-sensitive lesions in the left lung. As far as we know, this is the first report documenting a case of an integrated therapy strategy using surgical resection with gefitinib treatment for MPLC displaying different EGFR and PTEN molecular profiles. The patient has been in progression free survival up to now. Our experience could provide a treatment strategy for patients with similar disease.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 13046